Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$72.28 - $90.54 $3.41 Million - $4.28 Million
-47,238 Closed
0 $0
Q3 2021

Nov 02, 2021

SELL
$71.68 - $78.83 $38,635 - $42,489
-539 Reduced 1.13%
47,238 $3.58 Million
Q2 2021

Aug 12, 2021

BUY
$70.31 - $77.77 $1.43 Million - $1.58 Million
20,291 Added 73.82%
47,777 $3.72 Million
Q1 2021

May 07, 2021

BUY
$68.86 - $81.11 $44,070 - $51,910
640 Added 2.38%
27,486 $2.12 Million
Q4 2020

Feb 05, 2021

BUY
$71.77 - $79.65 $22,607 - $25,089
315 Added 1.19%
26,846 $2.17 Million
Q3 2020

Nov 12, 2020

SELL
$73.18 - $82.95 $28,467 - $32,267
-389 Reduced 1.45%
26,531 $2.19 Million
Q2 2020

Sep 04, 2020

SELL
$70.42 - $80.13 $926,656 - $1.05 Million
-13,159 Reduced 32.83%
26,920 $2.07 Million
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $939,261 - $1.07 Million
13,338 Added 49.88%
40,079 $3.63 Million
Q1 2020

May 13, 2020

SELL
$63.36 - $87.82 $780,024 - $1.08 Million
-12,311 Reduced 31.52%
26,741 $2.04 Million
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $80,796 - $88,071
-1,062 Reduced 2.65%
39,052 $3.29 Million
Q2 2019

Jul 30, 2019

BUY
$69.84 - $81.59 $271,118 - $316,732
3,882 Added 10.71%
40,114 $3.35 Million
Q1 2019

Apr 24, 2019

BUY
$69.58 - $79.36 $63,178 - $72,058
908 Added 2.57%
36,232 $3.01 Million
Q4 2018

Feb 08, 2019

SELL
$65.24 - $75.71 $2.54 Million - $2.95 Million
-38,911 Reduced 52.42%
35,324 $2.69 Million
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $170,531 - $200,535
2,956 Added 4.15%
74,235 $5.27 Million
Q2 2018

Aug 10, 2018

BUY
$50.83 - $59.72 $3.62 Million - $4.26 Million
71,279 New
71,279 $4.33 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Ninety One Sa (Pty) LTD Portfolio

Follow Ninety One Sa (Pty) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ninety One Sa (Pty) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ninety One Sa (Pty) LTD with notifications on news.